Summary The effects of cholera toxin (CT) and 8-chloro-cAMP (8-Cl-cAMP) on cell growth were investigated using two human pancreatic carcinoma cell lines (MIA PaCa-2, Panc-1). CT, which catalyses the ADP ribosylation of Gs, suppresses the proliferation of MIA PaCa-2(PC) cells. CT at the low dose of 0.1 pg ml ' was inhibitory of PC cell growth, and the maximum suppression (70%) was achieved at a CT concentration of 100 pg ml-'. This phenomenon was reversible. The production of cAMP by CT (100 pg ml-') in PC cells was enhanced 320-fold compared with the control. In addition, cAMP analogues (8-Cl-cAMP, 8-Br-cAMP) and forskolin decreased the growth rate of PC cells in a dose-dependent manner. These results support the view that CT suppresses PC cell growth by stimulating cAMP production. Conversely, Panc-l cells were far less sensitive to CT in cell growth and cAMP production. 8-Cl-cAMP was also less effective on Panc-l cell growth.
The bacterial exotoxin, cholera toxin (CT), is known to bind with high affinity to monosialoganglioside GM, on the cell surface and stimulate ADP-ribosylation of the stimulating G protein of adenylate cyclase, Gs. Activated adenylate cyclase eventually leads to an increase of intracellular cAMP level in most cellular systems (Holmgren, 1981) . Modulation of cellular function by CT has been reported, including modification of cell growth by the toxin. For example, CT stimulates the growth of cultured human mammary epithelial cells (Taylor-Papadimitriou et al., 1980) , Swiss 3T3 cells (Rozengurt et al., 1981) , and epithelial cells from normal human bronchus (Lechner et al., 1981) , in the presence of serum or growth factors. In contrast, it has also been shown that CT inhibits TGF-,B-induced monolayer growth of fibroblast cells (How et al., 1989) and the proliferation of hormone-dependent rat mammary cancer cells (Cho-Chung et al., 1983) and human small-cell lung cancer cells (Viallet et al., 1990) . Although the mechanism(s) of CT-induced cellular events is not definitely known at present, it is believed that increased intracellular cAMP is a participating element.
However, Viallet et al. have reported that elevation of cellular cAMP alone can not account for CT-induced growth inhibition of human small-cell lung cancer (Viallet et al., 1990) .
On the other hand, the physiological actions of cAMP, a second messenger in a variety of extracellular signals, have been studied widely and extensively using its analogues. Among these analogues, 8-Cl-cAMP has been found to bind selectively to the site 1 receptor of the type II regulatory subunit (Cho-Chung, 1990 ). This site-selective cAMP analogue inhibits the cell growth of human colon cancer cell (Ally et al., 1988; Tagliaferri et al., 1988) , leukemia cells , lung cancer cells , gastric cancer cells (Takanashi et al., 1991) , and Ki-rastransformed rat fibroblasts ).
Previously, we have shown that the growth of human pancreatic cancer cells (MIA PaCa-2) is enhanced by transforming growth factor (TGF)-x and insulin-like growth factor (IGF)-I in an autocrine manner (Ohmura et al., 1990) . In the present study, we demonstrate that CT and 8-Cl-cAMP suppress pancreatic cancer cell growth, and the mechanism(s) of actions of these substances was also investigated, in relation to the above two growth factors and K-ras oncogene, where the point mutation is frequently observed in pancreatic carcinomas (Barbacid, 1987; Barbacid, 1990 Immunoblotting Subconfluent PC cells cultured in 5% FCS/DMEM were collected and suspended in 5 ml 10 m mol I`Tris-HCl (pH; 7.4) containing 10% sucrose, m mol I`phenylmethylsulfonyl fluoride (PMSF) and 50 units ml-' aprotinin. Cells were homogenised with a Teflon glass homogeniser, sonicated for 2 min, and then centrifuged at 600 g for 10 min. Supernatants were centrifuged at 20,000 g for 40 min. The pellets were suspended in 0.5 ml 10 m mol-1 Tris-HCl (pH; 7.4) containing 0.15 mol 1' NaCl, 0.01 mol 1-1 MaCl2, 0.5% Nonidet P-40, m mol 1`PMSF, and 50 units ml-' aprotinin. The suspension was centrifuged at 20,000 g for 40 min at 4°C. Supernatants (300 jIg protein/lane) were separated by 17% SDS-PAGE and transferred to Clear Blot Membrane-P (Atto, Tokyo, Japan). K-ras p21 (Oncogene Science, Inc. Manhasset, NY) was used for the control antigen. After blocking with 3% BSA, the membranes were incubated with monoclonal antibody to K-ras p21 (Oncogene Science, Inc.) or normal mouse IgG for 20 h at 4°C and then incubated with '251-labelled protein A for 16 h at 4°C. They were exposed to an X-ray film (Fuji X-ray, Tokyo, Japan) at -70°C for 3-4 days. The quantitative analysis was performed with Video densitometer (Nippon Bio Rad Lab. Tokyo, Japan).
Results
Effect of CT on growth and cAMP production in PC or Panc-J cells As shown in Figure la , CT suppressed PC cell growth in the absence (0.3% BSA) or presence of 5% FCS. Half the maximum suppressive dose (IC50) of CT was between 10-100 pg ml-'. The inhibitory effect of the toxin appears to be reversible because PC cells grew again after the elimination of CT in the medium (Figure 2 ). In contrast, CT was far less effective on the cell growth of Panc-1 cells, another pancreatic cancer cell line (Figure lb) . It is generally assumed that the action of CT is attributed in part to cAMP stimulated by the toxin. To address this possibility, we observed the cAMP production of these two kinds of cells exposed to CT. As shown in Figure 3 , at low levels of 1 pg ml-' CT was able to stimulate cAMP production in PC cells. At a concentration of 100 pg ml-' of the toxin, the production of cAMP was enhanced 320-fold (control;
16.4 ± 0.8 nmol l-', CT 100 pgml1'; 5230 + 456 nmol l-'). Panc-1 cells, however, were less sensitive to CT in cAMP production (control; 14.3 ± 2.2 nmol l-1, CT 100 pg ml-';
1408 ± 89 nmol 1-l).
Effects of cAMP analogues andforskolin on cell growth of PC cells To clarify the mechanism of the growth-inhibitory effect of CT, the growth responses to cAMP analogues were inves- Effect of CT and 8-Cl-cAMP on levels of K-ras p21 in PC cells It has been suggested that mutated ras p21, a product of the ras oncogene, is responsible for the development of many types of cancer. In particular, the point mutation of K-ras oncogene is frequently (80%-90%) observed in human pancreatic cancer. This prompted us to examine whether K-ras p21 is modulated or not in PC cells treated by CT or 8-Cl-cAMP. As shown in Figure 5a of 27-242 ng ml1' (Viallet et al., 1990) , which is higher than that observed in PC cells. Such a difference between the cell types in the sensitivity of the cells to CT may be explained partly by the difference of the expression of cellular binding sites for CT, i.e. GM ganglioside (Viallet et al., 1990) . Although the precise mechanism of CT-induced growth inhibition is not clear at present, it is generally assumed that increases in cellular cAMP may be involved in the growth inhibition by CT. However, the existence of a different mechanism is suggested in the action of CT. Proliferation in such conditions as small-cell lung cancer, which is sensitive to CT, but not inhibited by cAMP analogues and forskolin, implies that CT acts through a cAMP-independent mechanism (Viallet et al., 1990) . In the present study, cellular cAMP production of PC cells was stimulated by CT ( Figure  3 ). Forksolin, which increases cellular cAMP, was also effective in suppressing PC cell growth. Further, the addition of 8-Cl-cAMP (Figure 4a, IC50 ; 10-50 pmol 11) or 8-BrcAMP (IC_v; 1mmoll1') inhibited the growth rate of PC cells. Such different IC,0 values may imply that the growth inhibition is not due to high concentration of nucleotides. Above observations suggest that the suppressive effect of CT is mediated, at least partly, through the increase of intracellular cAMP enhanced by the toxin. Previously, we have reported that IGF-I and TGF-a act as autocrine growth stimulators in PC cell growth (Ohmura et al., 1990) . This prompted us to determine whether the receptors for these growth factors are modified by CT or 8-ClcAMP. The results showed that CT and 8-Cl-cAMP had no substantial effects on the bindings of these peptide to PC cells, suggesting that the growth inhibition by CT or 8-ClcAMP does not occur at the binding sites of IGF-I or TGF-a. With regard to EGF/TGF-o receptor, it has been reported that 8-Cl-cAMP does not modify EGF-receptor mRNA in human gastric carcinoma cell lines (Takanashi et al., 1991) , which is consistent with our own observations. The ras oncogenes, which are associated with many types of tumours, acquire their transforming property either by single point mutations or over-expression of the normal ras p21 (Barbacid, 1987; Barbacid, 1990) . In particular, activating mutations of the K-ras gene at codons 12, 13, or 61, have been frequently (90%) observed in human pancreatic cancers, and it is a higher rate than those found in other human tumours. Although the functional roles of activated K-ras oncogenes are not clear, it has been speculated that the oncogene products play important roles in signal transductions because of their structural and biochemical similarities to G protein (Barbacid, 1987; Barbacid, 1990) . When antibodies specific for amino acid 12 of v-Ki-ras protein are microinjected into cells transformed by this protein, the cells transiently reverse to a normal phenotype (Feramisco et al., 1985) . According to a recent report, when the expression of the mutated ras p21 was down-regulated by anti-sense RNA, the growth of human cancer cells was inhibited, suggesting that the mutated p21 protein contributes to the faster growth rate of these cells (Mukhopadhyay et al., 1991) . To determine whether CT or 8-Cl-cAMP modifies K-ras p21 production, the protein of PC cells, in which the point mutation was also observed at codon 12 (data not shown), was analysed by Western blotting. Our results, however, demonstrate that CT and 8-Cl-cAMP increased K-ras p21 at 24 h. The relationship between 8-Cl-cAMP and ras p21 has been shown by other investigators in different cell lines. In human lung carcinoma, the expression of N-ras mRNA is increased by 8-Cl-cAMP at 1 h and 6 h; however, it is decreased at 7 days . Also, H-ras mRNA expression was increased in gastric cancer cells exposed to 8-Cl-cAMP for 24 h and 48 h (Takanashi et al., 1991) . Our results are consistent with these observations. Chesa et al. have reported that terminally differentiated cells showed stronger reactivity with antibody against ras p21 than did rapidly proliferating cells (Chesa et al., 1987) . Thus, it may be likely that there is a relationship between growth inhibition by CT or 8-Cl-cAMP and increased K-ras p21. By contrast, there are reports which indicate that 8-Cl-cAMP reduces the p21 level: 8-Cl-cAMP treatment for 3 days caused reduction of p21 in breast cancer cell lines (Taglioferri et al., 1988) ; 8-Cl-cAMP treatment also decreased the levels of p21 protein in K-ras-transformed rat fibroblasts . This discrepancy may be explained partly by differences in the cells used and/or antibody, i.e. we employed specific anti-K-ras p21 antibody, which did not react with either H-or N-ras p21, whereas some investigators used an antibody that reacts with whole p21 protein. However, the exact roles of K-ras p21 on PC cell growth remains to be elucidated.
As already indicated, activators of protein kinase C, such as TPA, decrease the affinity or number of EGF receptors (Shoyab et al., 1979; Lee & Weinstein, 1978) and stimulate the phosphorylation of the EGF receptor to inhibit its functions (Iwashita & Fox, 1984; Cochet et al., 1984) . We have also shown that TPA markedly reduces the affinity of EGF/ TGF-a receptor in PC cells and possibly causes growth inhibition by TPA (Ohmura et al., 1990) . Our present study revealed that CT and 8-Cl-cAMP did not reduce the binding TPA (n mol 1-') 5r of EGF, suggesting that these substances and TPA act through different mechanisms. This prompted us to examine the interaction between CT or 8-Cl-cAMP and TPA. As shown in Figure 6 , suppressed PC cell growth by almost maximum dose of 8-Cl-cAMP was further inhibited by TPA, but not by CT. Similarly CT-induced growth inhibition was further suppressed by TPA. These data support the view that the inhibitory action of CT or 8-Cl-cAMP is different from that of TPA, and a combination of these substances strengthens the anti-proliferative effect of each.
In conclusion, we have shown that CT and 8-Cl-cAMP suppress PC cell growth; the mechanism is presumably different from that of TPA. The finding that the action of CT or 8-Cl-cAMP is enhanced by TPA raises the possibility that a combination of these substances may be useful for the growth control of malignant cells.
